The Food and Drug Administration (FDA) has
approved updated COVID-19 vaccines for the 2024-2025 respiratory virus season. These vaccines are specifically formulated to target currently circulating variants, which have led to a recent surge in COVID-19 infections nationwide.
Residents of long term care facilities are strongly encouraged to receive a COVID-19 vaccine this fall. The FDA states that individuals 12 years and older are eligible to receive a single dose of the updated Comirnaty (Pfizer) or Spikevax (Moderna) vaccines.If previously vaccinated, the dose should be administered at least two months after the last dose of any COVID-19 vaccine.
With the approval of these COVID-19 vaccines, alongside the already approved influenza and RSV vaccines, long term care providers should contact their pharmacy or vaccine supplier to arrange ordering for administration this fall.
For additional support and information, providers can access
#GetVaccinated resources, designed to help ensure smooth vaccine distribution and communication efforts.
READ MORE